Page last updated: 2024-10-31

mianserin and Acute Relapsing Multiple Sclerosis

mianserin has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Damasceno, A1
von Glehn, F1
Martinez, AR1
Longhini, AL1
Deus-Silva, L1
Brandão, CO1
Santos, LM1
Damasceno, BP1

Other Studies

1 other study available for mianserin and Acute Relapsing Multiple Sclerosis

ArticleYear
Early onset of natalizumab-related progressive multifocal leukoencephalopathy.
    Multiple sclerosis (Houndmills, Basingstoke, England), 2011, Volume: 17, Issue:11

    Topics: Antibodies, Monoclonal, Humanized; Glatiramer Acetate; Humans; Immunologic Factors; Immunosuppressiv

2011